Monday, April 15, 2013

Acorda Therapeutics rises after saying Ampyra helped stroke patients recover walking ability

You can be one of those patients doctors hate by bringing your ideas for recovery to them.
http://www.therepublic.com/view/story/ff72a246ba664430869d79eb8ae273a7/US--Acorda-Therapeutics-Strokes
Acorda said patients who took Ampyra recovered were able to walk faster and had an easier time performing daily tasks. The trial involved 83 patients who had an ischemic stroke at least six months earlier, and who still had walking problems. Ischemic strokes occur when a blood vessel that supplies blood to the brain is blocked.
The company said it is still evaluating results from the study. The main goal of the trial was to measure Ampyra's safety and side effects in stroke patients, and the most common side effects included dizziness, nausea, fatigue, insomnia, and joint pain.
Ampyra is used to improve walking in patients with multiple sclerosis. Acorda markets the drug in the U.S., and Biogen Idec Inc. sells it as Fampyra in other countries. Biogen makes royalty payments to Acorda on those sales. Acorda is also studying Ampyra as a treatment for cerebral palsy.

More at link. And your doctor will know lots more you hope.

No comments:

Post a Comment